Global Pharmaceuticals & Biotech Most Popular Stocks

Cumberland Pharmaceuticals

Market Cap: US$46.2m

A specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally.

HLB Pep

Market Cap: ₩64.5b

A bio-venture company, engages in the manufacture and sale of peptide biomaterials and drug raw materials in South Korea and internationally.

SymBio Pharmaceuticals

Market Cap: JP¥6.8b

Engages in the research and development, manufacturing, and sales of pharmaceuticals and related operations to treat cancer, hematology, and viral infectious diseases in Japan and internationally.

Influx Healthtech

Market Cap: ₹4.1b

Operates as a contract development and manufacturing organization that provides a range of healthcare products in India.

Maverick Lifestyle

Market Cap: US$45.4m

Engages in the manufacture, branding, marketing, distribution, and sale of products infused with hemp-derived cannabinoids in the United States.

Medico Remedies

Market Cap: ₹4.0b

Develops, manufactures, and sells pharmaceutical and nutraceutical products in India.

J. Molner

Market Cap: €38.4m

A pharmaceutical company, provides research and development services for pharmaceutical companies in the United States, Canada, and Europe.

Radiopharm Theranostics

Market Cap: AU$68.6m

A clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs.

SCYNEXIS

Market Cap: US$45.1m

A biotechnology company, develops medicines to overcome and prevent difficult-to-treat and drug-resistant infections in the United States.

RP Bio

Market Cap: ₩63.1b

A bio-health company, engages in the research, development, manufacture, and sale of soft capsules in Korea and internationally.

Brooks Laboratories

Market Cap: ₹4.0b

Provides contract development and manufacturing services for pharmaceutical companies in India and internationally.

Infinium Pharmachem

Market Cap: ₹4.0b

Engages in the manufacture and supply of iodine, iodine derivatives, and active pharmaceutical ingredients (APIs) in India and internationally.

Korea Arlico PharmLtd

Market Cap: ₩62.8b

Engages in the researches and develops, produces, and sells medicines in South Korea.

D. Western Therapeutics Institute

Market Cap: JP¥6.7b

A biotechnology company, focuses on discovery and development of various drugs.

Nyrada

Market Cap: AU$68.1m

A pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular and neurological diseases.

Estrella Immunopharma

Market Cap: US$44.5m

A clinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States.

Everest Organics

Market Cap: ₹3.9b

Engages in the manufacture and sale of active pharmaceutical ingredients and its intermediaries in India.

House of Jane

Market Cap: US$44.1m

Provides lifestyle therapy products.

Century Therapeutics

Market Cap: US$44.0m

A clinical-stage biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases.

WDB coco

Market Cap: JP¥6.5b

Provides contract services to pharmaceutical companies in Japan.

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret

Market Cap: ₺1.8b

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S.

Arecor Therapeutics

Market Cap: UK£32.7m

A clinical stage biotechnology company, develops innovative medicines that address significant unmet patient needs in the United Kingdom.

Central Pharmaceutical No3

Market Cap: ₫1.2t

Engages in the manufacturing and sale of pharmaceutical products primarily in Vietnam and internationally.

Sernova Biotherapeutics

Market Cap: CA$60.8m

Operates as a clinical-stage biotechnology company in Canada.

Medicamen Biotech

Market Cap: ₹3.9b

A pharmaceutical company, research, develops, manufactures, markets, sells, and distributes pharmaceutical formulations in India and internationally.

Great Novel Therapeutics Biotech & Medicals

Market Cap: NT$1.3b

Engages in the development of drugs for the treatment of advanced and refractory cancers.

MOA Life Plus

Market Cap: ₩60.6b

Engages in the medicine and consumer business in South Korea.

RenovoRx

Market Cap: US$43.2m

A clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment.

Outlook Therapeutics

Market Cap: US$43.1m

Operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications.

CalciMedica

Market Cap: US$43.0m

A clinical-stage biopharmaceutical company, focuses on developing therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage.

Ascelia Pharma

Market Cap: SEK 402.0m

A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.

Grace Therapeutics

Market Cap: US$42.7m

Engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.

Marinomed Biotech

Market Cap: €36.3m

A biopharmaceutical company, develops therapeutic products for indications in virology and immunology in Austria, other European countries, and internationally.

Moberg Pharma

Market Cap: SEK 400.0m

A pharmaceutical company, develops and commercializes medical products primarily in Sweden.

BrightPath Biotherapeutics

Market Cap: JP¥6.3b

Engages in the development of cancer immunotherapy drugs in Japan.

Magle Chemoswed Holding

Market Cap: SEK 398.5m

Engages in research and development of pharmaceutical and medical device products in Sweden.